The current financial score of Core Laboratories Inc is 7.55. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 124.61M, representing a year-over-year decrease of 4.26%, while its net profit experienced a year-over-year decrease of 44.00%.
The current valuation score of Core Laboratories Inc is 7.87. Its current P/E ratio is 16.78, which is 276.91% below the recent high of 63.24 and 10.63% above the recent low of 15.00.
The current earnings forecast score of Core Laboratories Inc is 6.00. The average price target is 15.00, with a high of 21.00 and a low of 11.00.
The current price momentum score of Core Laboratories Inc is 3.93. Currently, the stock price is trading between the resistance level at 12.14 and the support level at 9.65, making it suitable for range-bound swing trading.
The current institutional shareholding score of Core Laboratories Inc is 10.00. The latest institutional shareholding proportion is 111.85%, representing a quarter-over-quarter decrease of 9.75%. The largest institutional shareholder is John Rogers, holding a total of 14.07M shares, representing 1.63% of shares outstanding, with 30.87% decrease in holdings.
The current risk assessment score of Core Laboratories Inc is 5.52. The company's beta value is 1.13. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.